Citigroup
BNTC icon

Citigroup’s Benitec Biopharma BNTC Stock Holding History

Citigroup’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Buy
9,851
+8,977
+1,027% +$106K ﹤0.01% 4533
2026
Q1 		$9.31K Buy
874
+330
+61% +$3.82K ﹤0.01% 5068
2025
Q4 		$7.33K Sell
544
-92
-14% -$1.27K ﹤0.01% 5145
2025
Q3 		$8.92K Sell
636
-4,503
-88% -$57.5K ﹤0.01% 5058
2025
Q2 		$60.1K Sell
5,139
-1,016
-17% -$14.2K ﹤0.01% 4663
2025
Q1 		$80.1K Sell
6,155
-6,308
-51% -$76.3K ﹤0.01% 4711
2024
Q4 		$157K Buy
+12,463
New +$135K ﹤0.01% 4566
2022
Q3 		– Sell
-202
Closed -$4K – 5845
2022
Q2 		$4K Buy
202
+201
+20,100% +$4.67K ﹤0.01% 5663
2022
Q1 		$0 Buy
+1
New +$41 ﹤0.01% 6313

Other funds holding BNTC

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

Citigroup's BNTC Position: Q2 2026 in Review

Citigroup increased its Benitec Biopharma (BNTC) stake by 1,027% in Q2 2026, buying an estimated $106K and bringing the position to 9,851 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #4533.

Citigroup first reported a position in BNTC in Q1 2022 and has held it in 9 quarters since. The position peaked at $157K in Q4 2024. 87 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Citigroup held 9,851 shares of Benitec Biopharma worth $132K as of Q2 2026.
  • Citigroup bought 8,977 Benitec Biopharma shares in Q2 2026, an estimated $106K.
  • Benitec Biopharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4533 holding.
  • Citigroup first reported a position in Benitec Biopharma in Q1 2022 and has held it in 9 quarters since.
  • Citigroup's Benitec Biopharma position peaked at $157K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.